SCHEMBL29144339

SCHEMBL29144339

Cc1cc([N+](=O)[O-])cc2c1CCNC2=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 8/20 0.50
▸ PARP11 Q9NR21 7/20 0.50
▸ PARP1 P09874 4/20 0.50
▸ TDP1 Q9NUW8 4/20 0.46
▸ MAPT P10636 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NCOA1 Q15788 1/20 0.46
▸ NCOA3 Q9Y6Q9 1/20 0.46
▸ HTR1D P28221 1/20 0.42
▸ HTR1B P28222 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.39
▸ TSHR P16473 2/20 0.39
▸ CYP3A4 P08684 2/20 0.38
▸ GPR35 Q9HC97 1/20 0.38
▸ ACHE P22303 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30019687 1.00 PARP10 (0.50) PARP10PARP11PARP1TDP1MAPT
SCHEMBL29698223 0.82 PARP10 (0.50) PARP10PARP11PARP1TDP1MAPT
SCHEMBL27689229 0.80 HTR1D (0.44) TDP1MAPTLMNAHTTNCOA1
SCHEMBL30855765 0.79 MAPT (0.44) PARP10PARP11PARP1TDP1MAPT
SCHEMBL6336167 0.78 ALDH1A1 (0.46) TDP1MAPTLMNAHTTHTR1D
SCHEMBL30019767 0.74 PARP10 (0.56) PARP10PARP11PARP1MAPTLMNA
SCHEMBL29144293 0.74 PARP10 (0.56) PARP10PARP11PARP1MAPTLMNA
SCHEMBL426331 0.72 PARP10 (0.57) PARP10PARP11PARP1TDP1MAPT
SCHEMBL27046251 0.72 PARP10 (0.49) PARP10PARP11PARP1
SCHEMBL24773896 0.71 PNMT (0.56) TDP1HTR1DHTR1BALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117242073-A PRMT5 inhibitors and uses thereof 海思科医药集团股份有限公司 2023-12-15 — — CN disclosed
WO-2022206964-A1 PRMT5 INHIBITOR AND USE THEREOF 海思科医药集团股份有限公司 2022-10-06 — — WO disclosed
Send feedback